loading...

UC.PT

IBILI

Rufino Martins Silva

Rufino Silva

Ophthalmologist.

Invited Professor of Ophthalmology, Faculty of Medicine, University of Coimbra Head of the Section of Medical Retina and Neurophthalmology at the Ophthalmology Department, CHUC.

Scientific Interest:

- Age-related Macular Degeneration

- Imaging and Genetic Biomarkers

- AMD epidemiology

- AMD, diet and lifestyle characterization in the he Portuguese population

- Clinical trials

5 Keys Publications:

  • Silva R, Cachulo ML, Fonseca P, Bernardes R, Nunes S, Vilhena N, Faria de Abreu JR. Age-Related Macular Degeneration and Risk Factors for the Development of Choroidal Neovascularisation in the Fellow Eye: A 3-Year Follow-Up Study. Ophthalmologica Ophthalmologica. 2011;226(3):110-8.
  • Silva R, Axer Siegel R, Elden B, Guimer R, Kirchof B, Papp A, Seres A, Gekkieva M, Nieveg A, Pilz S, for the Secure Study The SECURE Study. Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-Related Macular Degeneration. Ophthalmology. 2013; 120:130-9.
  • Silva R, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregório T, Luz Cachulo M, Pires I,. Cunha-Vaz JG, Murta JN. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study. Retina. 2013;33(2):309-315.
  • Aslam T, Delcourt C, Silva R, Holz F, Leys A, Layana AG, Souied E. Micronutrients in Age-Related Macular Degeneration. Ophthalmologica 2013;229(2):75-9.
  • Marques I, Fonseca P, Cachulo ML, Pires I, Figueira I, Faria de Abreu JR, Silva R. Treatment of Exudative AMD with Intravitreal Ranibizumab in Clinical Practice: a 3-year Follow-up. Ophthalmologica. 2013;229:158-167
Tel:+351 239480121
Office: AIBILI Building, CEC
Email: rufino.silva@oftalmologia.co.pt